R. Abraham
Molecular Biology · Cell · 2000–2017
A researcher in the Science corpus: 6 papers; trusts 17 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 89 citations into it; #4,504 of 17,773 by trust here, #5,282 by citations
- Cancer Research — 30 citations into it
- Oncology — 25 citations into it; #214 of 1,698 by trust here, #1,023 by citations
- Genetics — 22 citations into it
- Cell Biology — 15 citations into it; #301 of 2,073 by trust here, #1,007 by citations
Whom R. Abraham trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Yosef Shiloh
- R. Scully
- Č. Venclovas
- J. Falck
- A. Gingras
- Stephen J. Elledge
- B. Manning
- T. Paull
- M. Cox
- T. Brummelkamp
Who trusts R. Abraham overall
- J. Bartek
- Stephen P. Jackson
- M. Kastan
- H. Okada
- James L. Riley
- J. Lukas
- Yosef Shiloh
- J. Smith
- C. Lukas
Papers from R. Abraham's perspective
Ordered by how strongly the researchers R. Abraham trusts endorse each paper. Same corpus, a different order for every researcher.
- ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway (Nature)
- DNA damage-induced activation of p53 by the checkpoint kinase Chk2. (Science)
- A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. (Current Biology)
- The DNA damage response: putting checkpoints in perspective (Nature)
- Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. (Genes & Development)
- In search of the tumour-suppressor functions of BRCA1 and BRCA2 (Nature)
- Cell cycle control and cancer. (Pathologie et biologie)
- Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation (Molecular and Cellular Biology)
- A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. (Cancer Research)
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
Their papers
- Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin (2002) — 1,171 citations
- Cell cycle checkpoint signaling through the ATM and ATR kinases. (2001) — 2,163 citations
- The PI3K pathway in human disease (2017) — 2,352 citations
- Tyrosine phosphorylation‐dependent activation of NF‐κB (2001) — 126 citations
- Jurkat T cells and development of the T-cell receptor signalling paradigm (2004) — 607 citations
- A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. (2000) — 787 citations